GOOD MANUFACTURING PRACTICES FOR TOPICAL PRODUCTS i.e. EXTERNAL PREPARATIONS (CREAMS, OINTMENTS, PASTES, MULSIONS, LOTIONS, SOLUTIONS, DUSTING POWDERS AND IDENTICAL PRODUCTS)
SCHEDULE M – GMP – PART 5 (TOPICAL PRODUCTS) Read More »
GOOD MANUFACTURING PRACTICES FOR ORAL LIQUIDS (SYRUPS, ELIXIRS, EMULSIONS AND SUSPENSIONS)
SCHEDULE M – GMP – PART 4 (ORAL LIQUIDS) Read More »
Standard Solutions For Limit Tests Preparation | Limit Tests Solutions Preparation |
STANDARD SOLUTIONS FOR LIMIT TESTS Read More »
GOOD MANUFACTURING PRACTICES FOR STERILE PRODUCTS, PARENTERAL PREPARATIONS (SMALL VOLUME INJECTABLES AND LARGE VOLUME PARENTERALS) AND STERILE OPHTHALMIC PREPARATIONS.
SCHEDULE M – GMP – PART 3 (PARENTERAL PREPARATIONS) Read More »
GOOD MANUFACTURING PRACTICES FOR ORAL SOLID DOSAGE FORMS (TABLETS AND CAPSULES)
SCHEDULE M – GMP – PART 2 (OSD) Read More »
Data integrity is the fundamental principle of ensuring that data is accurate, reliable, and consistent throughout its entire lifecycle.
Data Integrity – ALCOA+ Read More »
Corrective and preventative action (CAPA) in pharma refers to the process of identifying, investigating, and addressing any issues or deviations that may have occurred during the production of pharmaceutical products.
What is CAPA – Corrective and preventative action Read More »
General information on Bursting Strength Tester
Bursting Strength Tester Read More »
SOP for Bursting Strength Tester | SOP for Cleaning and Operation of Bursting Strength Tester |
SOP for Bursting Strength Tester Read More »
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an organization that develops guidelines and standards to ensure the global harmonization of the development, registration, and post-approval phases of pharmaceutical products. ICH brings together regulatory authorities and the pharmaceutical industry to create consensus on various aspects of drug development.
